Skip to main content
Signal8

BioCorRx Inc. (BICX) Form 10-Q — May 15, 2026

$BICXForm 10-QFiled May 15, 2026, 9:31 AM ET0001477932-26-003159Original filing

BioCorRx Inc. reported a net loss of $859,892 for the three months ended March 31, 2026, driven by operating expenses of $1.17M that outpaced revenue of $214,539. The company’s cash position stands at a critically low $211,911 against a working capital deficit of $7.5 million. The filing includes explicit going-concern language, stating that these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve-month period.

Key figures

Revenue
214539
Revenue Yoy
59.0%
Cash Position
211911
Rd Expense
352333
Grant Income
362597
Shares Outstanding
28906559
Options Outstanding
1669075
Warrants Outstanding
4790885

Price after filing

1 day: 0.0%7 days: -19.2%30 days: -23.2%

Close on the filing date to close N calendar days later (from $0.49). Historical, not a forecast.

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.